Rubicon Research

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE506V01022
  • NSEID: RUBICON
  • BSEID: 544578
INR
1,519.10
-14.6 (-0.95%)
BSENSE

Oct 09

BSE+NSE Vol: 62.61 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

62.61 k (-11.45%) Volume

Shareholding (Jun 2026)

FII

7.52%

Held by 39 FIIs

DII

9.43%

Held by 18 DIIs

Promoter

59.76%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 25,120 Cr ()

stock-summary
P/E

89.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.10%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

19.83

Revenue and Profits:
Net Sales:
534 Cr
(Quarterly Results - Jun 2026)
Net Profit:
85 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.1%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
8.03%
0%
8.03%
6 Months
77.4%
0%
77.4%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Rubicon Research for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Closure of Trading Window

28-Sep-2026 | Source : BSE

Intimation of Trading Window Closure

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

29-Aug-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for General Atlantic Singapore RR Pte Ltd

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

27-Aug-2026 | Source : BSE

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for General Atlantic Singapore RR Pte Ltd

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Rubicon Research Ltd has declared 150% dividend, ex-date: 07 Aug 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
6.10
Debt to EBITDA (avg)
1.50
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.16
Tax Ratio
23.02%
Dividend Payout Ratio
0.23%
Pledged Shares
0
Institutional Holding
16.95%
ROCE (avg)
25.58%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
89
Industry P/E
36
Price to Book Value
19.83
EV to EBIT
71.90
EV to EBITDA
63.77
EV to Capital Employed
20.36
EV to Sales
14.55
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
28.31%
ROE (Latest)
19.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
RSI
No Signal
Bollinger Bands
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 14 Schemes (7.23%)

FIIs

Held by 39 FIIs (7.52%)

Promoter with highest holding

General Atlantic Singapore Rr Pte Ltd (35.83%)

Highest Public shareholder

Shivanand Shankar Mankekar Huf (13.52%)

Individual Investors Holdings

3.46%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 9.71% vs 29.22% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 17.75% vs 88.33% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "427.73",
          "val2": "389.88",
          "chgp": "9.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "124.83",
          "val2": "106.17",
          "chgp": "17.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "6.01",
          "val2": "5.40",
          "chgp": "11.30%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "82.45",
          "val2": "70.02",
          "chgp": "17.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.18%",
          "val2": "27.23%",
          "chgp": "1.95%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Rubicon Research"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Rubicon Research"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,753.96",
          "val2": "1,284.27",
          "chgp": "36.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "400.24",
          "val2": "264.26",
          "chgp": "51.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "42.17",
          "val2": "36.78",
          "chgp": "14.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "246.74",
          "val2": "134.36",
          "chgp": "83.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "22.82%",
          "val2": "20.58%",
          "chgp": "2.24%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Jun'26 - QoQstock-summary
Jun'26
Mar'26
Change(%)
Net Sales
427.73
389.88
9.71%
Operating Profit (PBDIT) excl Other Income
124.83
106.17
17.58%
Interest
6.01
5.40
11.30%
Exceptional Items
0.00
0.00
Standalone Net Profit
82.45
70.02
17.75%
Operating Profit Margin (Excl OI)
29.18%
27.23%
1.95%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2026 is 9.71% vs 29.22% in Mar 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Jun 2026 is 17.75% vs 88.33% in Mar 2026

Annual Results Snapshot (Consolidated) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
1,753.96
1,284.27
36.57%
Operating Profit (PBDIT) excl Other Income
400.24
264.26
51.46%
Interest
42.17
36.78
14.65%
Exceptional Items
0.00
0.00
Consolidate Net Profit
246.74
134.36
83.64%
Operating Profit Margin (Excl OI)
22.82%
20.58%
2.24%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 36.57% vs 50.40% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is 83.64% vs 47.63% in Mar 2025

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details